Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06368726
PHASE1

Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders

Sponsor: Citlalli Mellado Balanzar

View on ClinicalTrials.gov

Summary

Results of the application of 100 sessions of tDCS for 12 months in children between 6 and 11 years old with autism spectrum disorder with rare diseases, genetic problems or PANDAS

Official title: Results of the Application of 80 Sessions of tDCS for 12 Months in Children Between 6 and 11 Years Old With Autism Spectrum Disorder With Rare Diseases, Genetic Problems or PANDAS

Key Details

Gender

All

Age Range

6 Years - 11 Years

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2024-04-01

Completion Date

2026-06-02

Last Updated

2026-04-09

Healthy Volunteers

No

Interventions

DEVICE

tDCS or Transcranial Direct Current Stimulation

We use weak currents applied over the child's scalp over 30 minutes twice a week during 100 days

DRUG

Risperidone

Risperidone Risperidone according to child's weighs

Locations (1)

Bigdata4brain LLC

Albuquerque, New Mexico, United States